Search results for "Pharmacotherapy"


 
Results 21 - 30 of about 62 for "Pharmacotherapy".
Sort by: Relevance | Newest | Oldest

New resources available on how to improve treatment of patients with obesity

Three new web-based interactive learning activities from ACP's Online Learning Center address treatment of patients with obesity and offer free CME/MOC credit.
https://immattersacp.org/weekly/archives/2021/01/26/2.htm
26 Jan 2021

‘Geriatric tsunami’ carries elderly obesity

By 2030, more than 20% of the U.S. population is expected to be over the age of 65, according to the U.S. Census Bureau. The expected rise in functional impairment in later years can be staved off with a healthy lifestyle.
https://immattersacp.org/archives/2017/02/elderly.htm
1 Feb 2017

MKSAP quiz: Severe anxiety and repetitive behavior

A 25-year-old man evaluated during a new patient visit is concerned about his ability to arrive on time at a new job because every morning before leaving his apartment, he feels compelled to perform multiple checks to ensure that all electronic devices are turned off and all windows and doors are locked. What is the most appropriate management?
https://immattersacp.org/weekly/archives/2021/08/03/3.htm
3 Aug 2021

How should internists address e-cigarette use?

Inconsistent data have divided expert opinion on the safety of electronic nicotine delivery systems.
https://immattersacp.org/archives/2016/11/ecigarettes.htm
1 Nov 2016

KDIGO guideline summary provides key points for treating diabetes, chronic kidney disease

Authors from the Kidney Disease: Improving Global Outcomes (KDIGO) Work Group provided a synopsis of key recommendations on comprehensive care, glycemic monitoring and targets, lifestyle interventions, antihyperglycemic therapies, and educational and integrated care approaches.
https://immattersacp.org/weekly/archives/2023/01/10/1.htm
10 Jan 2023

Guideline suggests prescription medications when lifestyle change ineffective for weight loss

For adults with obesity or overweight with weight-related complications, the American Gastroenterological Association found moderate certainty of benefit for four medications: semaglutide, liraglutide, phentermine-topiramate ER, or naltrexone-bupropion.
https://immattersacp.org/weekly/archives/2022/10/25/1.htm
25 Oct 2022

Corticosteroids have fallen out of favor for COPD care

A single study has gone a long way toward changing clinical practices.
https://immattersacp.org/archives/2017/01/COPD-care.htm
1 Jan 2017

Multiple agents effective for excessive daytime sleepiness but may be discontinued due to side effects, review finds

A systematic review and meta-analysis of 14 trials found that solriamfetol, armodafinil-modafinil, and pitolisant were associated with reduced daytime sleepiness but also with headache, insomnia, and anxiety in patients with obstructive sleep apnea.
https://immattersacp.org/weekly/archives/2023/05/09/1.htm
9 May 2023

More options available for psoriatic arthritis

Internists are the first doctors patients see for joint pain, which means they can make a big difference in preventing the progression of joint diseases such as psoriatic arthritis.
https://immattersacp.org/archives/2019/04/more-options-available-for-psoriatic-arthritis.htm
1 Apr 2019

USPSTF recommends screening for unhealthy drug use in adults

This new statement replaces the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation, which concluded that the evidence at that time was insufficient to assess the balance of benefits and harms of screening.
https://immattersacp.org/weekly/archives/2020/06/16/4.htm
16 Jun 2020

Result Page: Prev   1   2   3   4   5   6   7   Next